Scientists have reported a major breakthrough in our understanding of inflammatory bowel disorder. It could lead to more effective treatments for conditions like Crohn's disease, a new study found.

A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

The findings, detailed in an article in The American Journal of Pathology can help advance the development of novel, targeted, naturally occurring probiotic therapy for patients with inflammatory ...

We’ve historically been obsessed with constipation. It’s shaped how we think about the gut, writes Elsa Richardson.

Advertisement Ulcerative colitis affects over 900,000 Americans and is a form of inflammatory bowel disease (IBD). The exact ...

A new study found that the average frequency of your bowel movements could impact your microbiome and risk of chronic disease ...

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

A three-day National Inflammatory Bowel Disease (IBD) Conference and the second roundtable meeting of the BRICS IBD Consortium, being organised by the Vizag Gut Club Association in collaboration with ...

Hidradenitis suppurativa is a chronic, systemic, and often painful skin condition. Here’s what it’s like living with it.

Tulisokibart is a tumor necrosis factor (TNF)-like cytokine 1A (TL1A) monoclonal antibody with a different mechanism of ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

A retrospective study of a mandatory nonmedical switch in Canada found no significant differences in rates of treatment persistence, loss of response, or adverse events in patients with inflammatory ...